IMIC issues a profit warning, expecting a net loss of 215 million to 280 million yuan for the fiscal year 2024

According to the Zhitong Finance APP, International Medical announced its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of between 215 million yuan and 280 million yuan for the year. During the reporting period, the company's overall medical business maintained a stable development trend, with continuous enhancement of disciplinary strength and steady growth in operating income, but the scale of operating income has not yet been able to cover operating costs and period expenses

According to the Zhitong Finance APP, International Medical (000516.SZ) released its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of between 215 million yuan and 280 million yuan for the whole year. During the reporting period, the company's overall medical business maintained a stable development trend, with continuous enhancement of disciplinary strength and steady growth in operating revenue, but the scale of operating revenue has not yet been able to cover operating costs and period expenses